— Know what they know.
Not Investment Advice

CARL NASDAQ

Carlsmed, Inc.
1W: +7.0% 1M: +4.7% 3M: +24.9% YTD: +5.8% 1Y: -15.1%
$12.31
+0.86 (+7.51%)
Pre-Market: $12.04 (-0.27, -2.15%)
Weekly Expected Move ±12.2%
$8 $9 $11 $12 $13
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 59 · $334.6M mcap · 9M float · 1.88% daily turnover · Short 52% of daily vol
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$334.6M
52W Range8.5-17.19
Volume150,707
Avg Volume170,306
Beta2.02
Dividend
Analyst Ratings
3 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOMichael Cordonnier
Employees127
SectorHealthcare
IndustryMedical - Devices
IPO Date2025-07-23
1800 Aston Avenue
Carlsbad, CA 92008
US
(760) 766-1923
About Carlsmed, Inc.

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Recent Insider Trades

NameTypeSharesPriceDate
OBOYLE KEVIN C A-Award 13,698 2026-06-03
Sidow Kevin A-Award 13,698 2026-06-03
ROOT JONATHAN D A-Award 13,698 2026-06-03
YOUNG PHILIP M A-Award 13,698 2026-06-03
Cordonnier Michael M-Exempt 33,264 $4.35 2026-03-03

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms